OrPro Therapeutics Presents Data for Lead Compound at Annual North American Cystic Fibrosis Conference

OrPro Therapeutics, Inc., a pre-clinical stage biopharmaceutical company, announced that it will present data on the development of its inhaled treatment for cystic fibrosis (CF) at the 28thAnnual North American Cystic Fibrosis Conference, October 9 – 11 in Atlanta. CF is an inherited … Continued

Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment

Parion Sciences today announced it has received a $3 million award from Cystic Fibrosis Foundation Therapeutics (CFFT) to support the development of P-1037, Parion’s new investigational treatment for cystic fibrosis (CF). This award will accelerate the initiation of a phase … Continued